Takeda Pharmaceutical Co Stock Market Value
| TKPHF Stock | USD 27.64 0.44 1.62% |
| Symbol | Takeda |
Takeda Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Takeda Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Takeda Pharmaceutical.
| 12/09/2022 |
| 11/28/2024 |
If you would invest 0.00 in Takeda Pharmaceutical on December 9, 2022 and sell it all today you would earn a total of 0.00 from holding Takeda Pharmaceutical Co or generate 0.0% return on investment in Takeda Pharmaceutical over 720 days. Takeda Pharmaceutical is related to or competes with Genomma Lab. Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of... More
Takeda Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Takeda Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Takeda Pharmaceutical Co upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.38 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 20.93 | |||
| Value At Risk | (6.08) | |||
| Potential Upside | 5.61 |
Takeda Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Takeda Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Takeda Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Takeda Pharmaceutical historical prices to predict the future Takeda Pharmaceutical's volatility.| Risk Adjusted Performance | 0.0252 | |||
| Jensen Alpha | 0.0039 | |||
| Total Risk Alpha | (0.50) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.1273 |
Takeda Pharmaceutical Backtested Returns
At this point, Takeda Pharmaceutical is not too volatile. Takeda Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0396, which indicates the firm had a 0.0396% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Takeda Pharmaceutical Co, which you can use to evaluate the volatility of the company. Please validate Takeda Pharmaceutical's Semi Deviation of 3.02, risk adjusted performance of 0.0252, and Coefficient Of Variation of 4422.89 to confirm if the risk estimate we provide is consistent with the expected return of 0.14%. Takeda Pharmaceutical has a performance score of 3 on a scale of 0 to 100. The entity has a beta of 0.57, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Takeda Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Takeda Pharmaceutical is expected to be smaller as well. Takeda Pharmaceutical right now has a risk of 3.56%. Please validate Takeda Pharmaceutical downside variance, and the relationship between the treynor ratio and kurtosis , to decide if Takeda Pharmaceutical will be following its existing price patterns.
Auto-correlation | -0.32 |
Poor reverse predictability
Takeda Pharmaceutical Co has poor reverse predictability. Overlapping area represents the amount of predictability between Takeda Pharmaceutical time series from 9th of December 2022 to 4th of December 2023 and 4th of December 2023 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Takeda Pharmaceutical price movement. The serial correlation of -0.32 indicates that nearly 32.0% of current Takeda Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.32 | |
| Spearman Rank Test | -0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 1.42 |
Takeda Pharmaceutical lagged returns against current returns
Autocorrelation, which is Takeda Pharmaceutical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Takeda Pharmaceutical's pink sheet expected returns. We can calculate the autocorrelation of Takeda Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Takeda Pharmaceutical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Takeda Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Takeda Pharmaceutical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Takeda Pharmaceutical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Takeda Pharmaceutical pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Takeda Pharmaceutical Lagged Returns
When evaluating Takeda Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Takeda Pharmaceutical pink sheet have on its future price. Takeda Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Takeda Pharmaceutical autocorrelation shows the relationship between Takeda Pharmaceutical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Takeda Pharmaceutical Co.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Takeda Pink Sheet
When determining whether Takeda Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Takeda Pink Sheet is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Takeda Pharmaceutical Co Stock. Highlighted below are key reports to facilitate an investment decision about Takeda Pharmaceutical Co Stock:Check out Takeda Pharmaceutical Correlation, Takeda Pharmaceutical Volatility and Takeda Pharmaceutical Alpha and Beta module to complement your research on Takeda Pharmaceutical. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Takeda Pharmaceutical technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.